GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Forward Dividend Yield %

Diamyd Medical AB (OSTO:DMYD B) Forward Dividend Yield % : 0.00% (As of Jul. 04, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Forward Dividend Yield %?

As of today (2025-07-04), the Forward Annual Dividend Yield of Diamyd Medical AB is 0.00%.

As of today (2025-07-04), the Trailing Annual Dividend Yield of Diamyd Medical AB is 0.00%.

OSTO:DMYD B's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.38
* Ranked among companies with meaningful Forward Dividend Yield % only.

Diamyd Medical AB's Dividends per Share for the three months ended in May. 2025 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Diamyd Medical AB's Forward Dividend Yield %

For the Biotechnology subindustry, Diamyd Medical AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Forward Dividend Yield % falls into.


;
;

Diamyd Medical AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Diamyd Medical AB  (OSTO:DMYD B) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Diamyd Medical AB Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines